Denosumab
Trade Name:
Prolia
Manufacturer/Distributor:
Amgen Canada
1 (800) 665-4273 ; Medical information 1 (866) 502-6436
Classification:
RANK Ligand inhibitor
ATC Class:
M05BX04 Denosumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/08/06
Date Marketed in Canada (yyyy/mm/dd):
2010/08/10
Presentation:
Injection: 60 mg/mL pre-filled syringe. DIN: 02343541
Comments:
Bone metabolism regulator for prevention of fractures in post-menopausal women with osteoporosis. Product is injected subcutaneously every six months.
| Posted | Updated |
|---|---|
| 2010-11-18 14:17 | 2010-11-18 14:28 |
Back to:
Drug Product Listings 
